Financial Daily from THE HINDU group of publications
Wednesday, Oct 13, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals


Pharma sector keeping an eye on US poll outcome

P.T. Jyothi Datta

The drug industry is keeping a close watch on the prospects that may open or close on them in case Mr John Kerry wins.

Mumbai , Oct. 12

IT may have been an unlikely venue for a discussion on the outcome of the Presidential elections in the US.

But the healthcare policies stated by the US President, Mr George Bush, and the Senator, Mr John Kerry, in their recent Presidential debates were discussed at a pharma conclave attended by the big guns in the Indian drug industry on Tuesday.

The drug industry is keeping a close watch on the prospects that may open or close on them in case Mr John Kerry wins.

Touching on the various cost pressures faced by big pharma, or the major multinational drug companies, Mr Satish Reddy, Managing Director and Chief Operating Officer, Dr Reddy's Laboratories Ltd, recalled the healthcare issues thrown up at the recent US Presidential debate.

"There are socio-economic pressures related to issues on medicare and the import of cheap drugs from Canada. And, this is putting pressure on the big pharma companies," he said.

Similar references were made by Mr Rupert Hill, Director of the European Healthcare Group, Merrill Lynch International.

Highlighting the different forces at play, he said that President Bush's Medicare Bill had been criticised by the Opposition members as a "draft by the pharmaceutical industry, for the pharmaceutical industry."

The plug will be pulled on import of cheaper drugs from Canada into the US, with safety issues being raised. If Mr Bush wins, the Medicare Bill will come into play by 2006.

But what will happen if Mr Kerry wins?

Canada's drug imports account for a small percentage of the US demand. Mr Kerry is in favour of importing inexpensive drugs from Canada and allowing more government involvement in pricing issues, Mr Hill said.

But who is better for the Indian pharma industry, Mr Bush or Mr Kerry?

"For US-based companies, which don't have the volumes, they are likely to get hurt by some of the proposed policies. The Indian generic drug industry has the volumes. So even if prices get eroded because of competition or some of the policies stated by either candidate, it is unlikely to hurt them," Mr Hill told Business Line.

More Stories on : Pharmaceuticals | Politics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Alert on coconut leaf rot


Brazil pares dumping duty on Indian jute imports
Consultant to draw roadmap for setting up chemical parks
Thought @ the speed of government
Industrial growth at 7.9 pc in August
Karnataka industries `reeling under tax burden'
Iraq invites investment in oil industry
Panel to catalyse Singapore investments in India set up
Chirac's China mission to pave way for major deals
Govt bans rofecoxib sale
Micro Labs dumps rofecoxib drug
Merck effect: Pharma cos scan pain relief options
SBI, LIC come together for funding infrastructure projects
Cabinet may take up Rs 450-cr PSU revamp package
ONGC set to recover dues from Gujarat PSUs
Pharma sector keeping an eye on US poll outcome
Bidding for global projects — PowerGrid ties up with Netherlands co
Melas to widen service tax net at Thiruvananthapuram
New Haryana plan to redress traders' woes soon
Additional export quota
UK bodies to train SME entrepreneurs
Voicing support
CIL targets 445 m.t output by 2011-12
Coal merchants object to be called as C&F agents
`Broadcasters' future lies in content ownership, copyright'
DD gets tough with pvt channels on Olympic footage
15,000 Indian students headed for UK
Ascendas, Mahindra to jointly develop ready-built space near Chennai
Sunil Alagh takes over as AIMA President
`HR person needs the right blend of theory, practice'
Chamber concern over road blockades
Three-pronged plan to boost textiles, clothing industry
`Govt expenses far more rigid than revenues'
In Thiruvananthapuram today
Seminar on asset valuation
In Hyderabad today
Entrepreneurship development programmes in AP
Reports on anti-piracy measures sought
Kanara Chamber submits action plan on tourism development



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line